We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-0.85%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$15.5B
AUM Growth
+$465M
Cap. Flow
+$685M
Cap. Flow %
4.42%
Top 10 Hldgs %
22.16%
Holding
2,692
New
671
Increased
625
Reduced
715
Closed
596

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.07B
2
INDA icon
iShares MSCI India ETF
INDA
+$125M
3
CSX icon
CSX Corp
CSX
+$73.9M
4
CHRW icon
C.H. Robinson
CHRW
+$71.1M
5
AAPL icon
Apple
AAPL
+$70.5M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$753M
2
UAL icon
United Airlines
UAL
+$87.7M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$74.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$71.4M
5
AMZN icon
Amazon
AMZN
+$66.5M

Sector Composition

Rank Sector Weight
1 Industrials 14.37%
2 Technology 11.84%
3 Consumer Discretionary 8.59%
4 Healthcare 7.01%
5 Financials 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMR icon
1926
Beamr Imaging
BMR
$20M
$54.8K ﹤0.01%
+10,500
New +$57.6K
NDLS icon
1927
Noodles & Co
NDLS
$108M
$54.3K ﹤0.01%
+4,297
New +$61.3K
EOSE icon
1928
Eos Energy Enterprises
EOSE
$1.38B
$52.8K ﹤0.01%
+41,600
New +$34.4K
EDIT icon
1929
Editas Medicine
EDIT
$422M
$52.1K ﹤0.01%
+11,153
New +$62.9K
PARA
1930
CALL
DELISTED
Paramount Global Class B
PARA
$52K ﹤0.01%
5,000
-5,000
-50% -$58.6K
NGD
1931
DELISTED
New Gold Inc
NGD
$50.1K ﹤0.01%
+25,700
New +$48.9K
KPTI icon
1932
Karyopharm Therapeutics
KPTI
$43.3M
$50K ﹤0.01%
+3,840
New +$63.6K
EGHT icon
1933
8x8 Inc
EGHT
$328M
$49.3K ﹤0.01%
+22,222
New +$54K
AGIG
1934
Abundia Global Impact Group
AGIG
$40.7M
$49.1K ﹤0.01%
3,810
-3,420
-47% -$50.4K
DHX icon
1935
DHI Group
DHX
$181M
$48.8K ﹤0.01%
+23,338
New +$54.1K
ICAD
1936
DELISTED
iCAD Inc
ICAD
$47.1K ﹤0.01%
36,200
-8,900
-20% -$13.7K
ANTX icon
1937
AN2 Therapeutics
ANTX
$210M
$46.8K ﹤0.01%
+21,774
New +$51.8K
WW
1938
DELISTED
WW International
WW
$46.8K ﹤0.01%
+40,000
New +$66.6K
OTLY
1939
Oatly Group
OTLY
$445M
$46.7K ﹤0.01%
+2,485
New +$52.8K
PMCB icon
1940
PharmaCyte Biotech
PMCB
$6.33M
$46.5K ﹤0.01%
23,700
+200
+0.9% +$431
OPI
1941
DELISTED
Office Properties Income Trust
OPI
$45.9K ﹤0.01%
+22,500
New +$48.9K
ACIU icon
1942
AC Immune
ACIU
$233M
$45.5K ﹤0.01%
+11,400
New +$37.7K
BCAB icon
1943
BioAtla
BCAB
$5.53M
$45.5K ﹤0.01%
+664
New +$79K
CTXR icon
1944
Citius Pharmaceuticals
CTXR
$21.4M
$45.3K ﹤0.01%
+3,104
New +$55.6K
BIG
1945
DELISTED
Big Lots, Inc.
BIG
$45.2K ﹤0.01%
+26,100
New +$84.3K
PDSB icon
1946
PDS Biotechnology
PDSB
$40.6M
$45.1K ﹤0.01%
+15,400
New +$49.3K
KYNB
1947
Kyntra Bio
KYNB
$28.3M
$43.9K ﹤0.01%
1,968
+388
+25% +$12K
NXTC icon
1948
NextCure
NXTC
$21.4M
$43.9K ﹤0.01%
2,300
-30,470
-93% -$593K
AIRE icon
1949
reAlpha
AIRE
$7.94M
$43.5K ﹤0.01%
1,832
-284
-13% -$7.17K
MCRB icon
1950
Seres Therapeutics
MCRB
$48.4M
$43.5K ﹤0.01%
+3,005
New +$50.1K
76 77
78
79 80

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Schonfeld Strategic Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Schonfeld Strategic Advisors held 2,692 positions worth $15.5B, up 3.1% from $15B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Schonfeld Strategic Advisors deployed $685M of net new capital in Q2 2024, opening 671 new positions and adding to 625 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 2,042,404 shares worth $1.12B.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $753M trimmed.

  • Schonfeld Strategic Advisors's largest Q2 2024 buy was iShares Core S&P 500 ETF: 2,042,404 shares worth $1.12B.
  • Schonfeld Strategic Advisors added most to CSX Corp in Q2 2024, an estimated $73.9M increase.
  • Schonfeld Strategic Advisors's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $753M.
  • Schonfeld Strategic Advisors fully exited iShares TIPS Bond ETF in Q2 2024, selling an estimated $41.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 22% of its $15.5B portfolio in Q2 2024.
  • Schonfeld Strategic Advisors opened 671 new positions and closed 596 in Q2 2024.
  • Schonfeld Strategic Advisors's portfolio value rose 3.1% quarter-over-quarter to $15.5B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.